Description

Hereditary Breast and Ovarian cancer study Netherlands (HEBON) we enrolled members of high risk families tested for BRCA1/2 mutations. With this study we actively participate in two international initiatives, the prospective International BRCA1/2 Carrier Cohort Study (IBCCS, coordinated at NKI) and the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA, epidemiologic part, coordinated at NKI).

Biological samples, DNA of women.
N=27000
Datum van beschikbaarheid2018
UitgeverAntoni van Leeuwenhoek
Geografische dekkingThe Netherlands

Citeer dit